Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | FGFR1 |
Variant | K656N |
Impact List | missense |
Protein Effect | unknown |
Gene Variant Descriptions | FGFR1 K656N lies within the protein kinase domain of the Fgfr1 protein (UniProt.org). K656N has been associated with resistance to FGFR inhibitors in culture (PMID: 34114373), and results in increased kinase activity of a truncated Fgfr1 construct in an in vitro assay (PMID: 26864631), but has not been fully biochemically characterized and therefore, its effect on Fgfr1 protein function is unknown. |
Associated Drug Resistance | Y |
Category Variants Paths |
FGFR1 mutant FGFR1 K656N |
Transcript | NM_023110.3 |
gDNA | chr8:g.38414788C>G |
cDNA | c.1968G>C |
Protein | p.K656N |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
XM_011544449.2 | chr8:g.38414196C>G | c.1968G>C | p.K656N | RefSeq | GRCh38/hg38 |
XM_017013221 | chr8:g.38414788C>G | c.1968G>C | p.K656N | RefSeq | GRCh38/hg38 |
XM_017013226.2 | chr8:g.38414196C>G | c.1968G>C | p.K656N | RefSeq | GRCh38/hg38 |
XM_017013221.2 | chr8:g.38414788C>G | c.1968G>C | p.K656N | RefSeq | GRCh38/hg38 |
NM_023110.3 | chr8:g.38414788C>G | c.1968G>C | p.K656N | RefSeq | GRCh38/hg38 |
XM_011544449.1 | chr8:g.38414196C>G | c.1968G>C | p.K656N | RefSeq | GRCh38/hg38 |
XM_006716303 | chr8:g.38414788C>G | c.1968G>C | p.K656N | RefSeq | GRCh38/hg38 |
NM_023110.2 | chr8:g.38414788C>G | c.1968G>C | p.K656N | RefSeq | GRCh38/hg38 |
XM_006716304 | chr8:g.38414788C>G | c.1968G>C | p.K656N | RefSeq | GRCh38/hg38 |
XM_006716303.3 | chr8:g.38414788C>G | c.1968G>C | p.K656N | RefSeq | GRCh38/hg38 |
XM_006716303.4 | chr8:g.38414788C>G | c.1968G>C | p.K656N | RefSeq | GRCh38/hg38 |
XM_011544450.2 | chr8:g.38414196C>G | c.1968G>C | p.K656N | RefSeq | GRCh38/hg38 |
NM_023110 | chr8:g.38414788C>G | c.1968G>C | p.K656N | RefSeq | GRCh38/hg38 |
XM_017013226 | chr8:g.38414196C>G | c.1968G>C | p.K656N | RefSeq | GRCh38/hg38 |
XM_011544450.3 | chr8:g.38414196C>G | c.1968G>C | p.K656N | RefSeq | GRCh38/hg38 |
XM_011544450 | chr8:g.38414196C>G | c.1968G>C | p.K656N | RefSeq | GRCh38/hg38 |
XM_006716304.1 | chr8:g.38414788C>G | c.1968G>C | p.K656N | RefSeq | GRCh38/hg38 |
XM_011544449 | chr8:g.38414196C>G | c.1968G>C | p.K656N | RefSeq | GRCh38/hg38 |
XM_017013221.1 | chr8:g.38414788C>G | c.1968G>C | p.K656N | RefSeq | GRCh38/hg38 |
XM_006716304.2 | chr8:g.38414788C>G | c.1968G>C | p.K656N | RefSeq | GRCh38/hg38 |
XM_017013226.1 | chr8:g.38414196C>G | c.1968G>C | p.K656N | RefSeq | GRCh38/hg38 |
XM_047421575.1 | chr8:g.38415855C>G | c.1968G>C | p.K656N | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
FGFR1 K656N | Advanced Solid Tumor | predicted - resistant | Erdafitinib | Preclinical - Cell culture | Actionable | In a preclinical study, cells expressing FGFR1 K656N demonstrated insensitivity to Balversa (erdafitinib) in culture (PMID: 34114373). | 34114373 |
FGFR1 K656N | Advanced Solid Tumor | predicted - sensitive | Olverembatinib | Preclinical - Cell culture | Actionable | In a preclinical study, Olverembatinib (HQP1351) inhibited growth of a cell line expressing FGFR1 K656N in culture (PMID: 34114373). | 34114373 |
FGFR1 K656N | Advanced Solid Tumor | predicted - sensitive | Infigratinib | Preclinical - Cell culture | Actionable | In a preclinical study, Truseltiq (infigratinib) inhibited growth of a cell line expressing FGFR1 K656N in culture (PMID: 34114373). | 34114373 |
FGFR1 K656N | Advanced Solid Tumor | predicted - sensitive | Futibatinib | Preclinical - Cell culture | Actionable | In a preclinical study, Lytgobi (futibatinib) inhibited growth of a cell line expressing FGFR1 K656N in culture (PMID: 34114373). | 34114373 |
FGFR1 K656N | Advanced Solid Tumor | predicted - resistant | Pemigatinib | Preclinical - Cell culture | Actionable | In a preclinical study, cells expressing FGFR1 K656N demonstrated insensitivity to Pemazyre (pemigatinib) in culture (PMID: 34114373). | 34114373 |